Search by Drug Name or NDC

    NDC 66869-0204-07 Livalo 2.09 mg/1 Details

    Livalo 2.09 mg/1

    Livalo is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Kowa Pharmaceuticals America, Inc.. The primary component is PITAVASTATIN CALCIUM.

    Product Information

    NDC 66869-0204
    Product ID 66869-204_1783ecd3-0116-4ad8-9a43-25d5b2dc62e6
    Associated GPIs 39400058100331
    GCN Sequence Number 066350
    GCN Sequence Number Description pitavastatin calcium TABLET 2 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 28594
    HICL Sequence Number 036983
    HICL Sequence Number Description PITAVASTATIN CALCIUM
    Brand/Generic Brand
    Proprietary Name Livalo
    Proprietary Name Suffix n/a
    Non-Proprietary Name pitavastatin calcium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.09
    Active Ingredient Units mg/1
    Substance Name PITAVASTATIN CALCIUM
    Labeler Name Kowa Pharmaceuticals America, Inc.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022363
    Listing Certified Through 2024-12-31

    Package

    NDC 66869-0204-07 (66869020407)

    NDC Package Code 66869-204-07
    Billing NDC 66869020407
    Package 7 TABLET, FILM COATED in 1 CARTON (66869-204-07)
    Marketing Start Date 2019-05-16
    NDC Exclude Flag N
    Pricing Information N/A